Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006)

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 3, 2008, Pages 291-294

  Yoo, Jeongsik ^a,d   Sohn, Eui Suk ^a   Chung, Gyung Tae ^a   Lee, Eun Hee ^b   Lee, Kyung Ryul ^c   Park, Yong Keun ^d   Lee, Yeong Seon ^a  

^a Korea National Institute of Health   (South Korea)

^b Green Cross Company   (South Korea)

^c Seoul Medical Science Institute   (South Korea)

^d Korea University   (South Korea)

Author keywords

Antimicrobial resistance; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; GENERAL HOSPITAL; HUMAN; IN VITRO STUDY; KOREA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TERTIARY HEALTH CARE; TREND STUDY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 39149125454     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.10.005     Document Type: Article

References (21)

1. Andrade S.S., Jones R.N., Gales A.C., and Sader H.S. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY antimicrobial surveillance program (1997-2001). J. Antimicrob. Chemother. 52 (2003) 140-141
2. Cavallo J.D., Hocquet D., Plesiat P., Fabre R., Delvallez M.R., and on behalf of GERPA. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study. J. Antimicrob. Chemother. 59 (2007) 1021-1024
3. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Document M100-S15 (2005), CLSI, Wayne, PA
4. European Antimicrobial Resistance Surveillance System (2006) Chapter 4. Antimicrobial Resistance in Europe, 4.7. Pseudomonas aeruginosa In EARSS annual report 2005. pp. 66-71.
5. Flamm R.K., Weaver M.K., Thornsberry C., Jones M.E., Karlowsky J.A., and Sahm D.F. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob. Agents Chmother. 48 (2004) 2431-2436
6. Friedland I., Stinson L., Ikaiddi M., Harm S., and Woods G.L. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a multicenter intensive care unit surveillance study, 1995-2000. Diagn. Microbiol. Infect. Dis. 45 (2003) 245-250
7. Gaynes R., Edwards J.R., and the National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 41 (2005) 848-853
8. Hancock R.E. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin. Infect. Dis. 27 Suppl. 1 (1998) S93-S99
9. Hatchette T.F., Gupta R., and Marrie T.J. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin. Infect. Dis. 31 (2000) 1349-1356
10. Hong S.G., Yong D., Lee K., Kim E.C., Lee W.K., Jeong S.H., Song W.K., Park Y.J., Kim M.N., Uh Y., Shin J.H., Lee J., Ahn J.Y., Lee S.W., Kim J.S., and Shin H.B. Antimicrobial resistance of clinically important bacteria isolated from hospital located in representative provinces of Korea. Korean J. Clin. Microbiol. 6 (2003) 29-36
11. Karlowsky J.A., Jones M.E., Thornsberry C., Evangelista A.T., Yee Y.C., and Sahm D.F. Stable antimicrobial susceptibility rates for clinical isolates of P. aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clin. Infect. Dis. 40 Suppl. 2 (2005) S89-S98
12. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., and Oh M.D. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia. Clin. Microbiol. Infect. 11 (2005) 402-421
13. Lambert P.A. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J. R. Soc. Med. 95 Suppl. 41 (2002) 22-26
14. Lee J.K., Sohn E.S., Yoo Y.S., Yoo J.I., Lee E.H., Lee K.R., Lee Y.S., and Kim B.S. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from non-tertiary care hospitals in Korea, 2002-2004. Infect. Chemother. 38 (2006) 1-10
15. Lee K., Park K.H., Jeong S.H., Lim H.S., Shin J.H., Yong D., Ha G.-.Y., Chong Y., and and KONSAR group. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. In Korea: 2003 KONSAR surveillance. Yonsei Med. J. 47 (2006) 43-54
16. Lee K., Lim C.H., Cho J.H., Lee W.G., Uh Y., Kim H.J., Yong D., Chong Y., and and KONSAR group. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. In Korea: a KONSAR program in 2004. Yonsei Med. J. 47 (2006) 634-645
17. Lee H.M., Kim C.K., Lee J.W., Lee S.H., Ahn J.Y., Hong S.G., Park Y.J., Jeong S.H., Kim E.C., Lee W.K., Uh Y., Shin J.H., Choi T.Y., Kwak H.S., and Lee K.W. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J. Clin. Microbiol. 10 (2007) 59-69
18. Lee Y.K. Study on the relationship of antibiotic use and resistance. Annual report of KFDA 6 (2002) 946-947
19. Obritsch M.D., Fish D.N., MacLaren R., and Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993-2002. Antimicrob. Agents Chemother. 48 (2004) 4606-4610
20. Rossi F., Baquero F., Hsueh P.-.R., Paterson D.L., Bochicchio G.V., Snyder T.A., Satishchandran V., McCarroll K., Dinubile M.J., and Chow J.W. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART(Study for Monitoring Antimicrobial Resistance Trends). J. Antimicrob. Chemother. 58 (2006) 205-210
21. Wang H., and Chen M. China nosocomial pathogens resistance surveillance study group: surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1999-2002. Diagn. Microbiol. Infect. Dis. 51 (2005) 201-208